Claims for Patent: 7,658,768

Summary for Patent: 7,658,768

Title:	Bone graft substitute composition
Abstract:	Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended.
Inventor(s):	Miller; Leasa C. (Covington, TN), Richelsoph; Kelly Coupe (Memphis, TN), Moseley; Jon P. (Arlington, TN)
Assignee:	Wright Medical Technology, Inc. (Arlington, TX)
Application Number:	11/872,564
Patent Claims:	1. A method of making a bone graft substitute composition, comprising the following steps: a) mixing calcium sulfate hemihydrate, a plasticizing material, and an aqueous mixing solution for a time sufficient to form a blend; b) waiting a predetermined period of time after forming the blend, wherein said predetermined period of time is at least about 30 seconds; and then c) mixing the blend and a demineralized bone material to produce the bone graft substitute composition. 2. The method of claim 1, wherein the blend is continuously mixed during the step b). 3. The method of claim 1, wherein said mixing of step a) comprises mixing for at least about 30 seconds to form the blend. 4. The method of claim 1, wherein the steps a) and b) have a combined time of at least about one minute. 5. The method of claim 1, wherein the blend further comprises an accelerant that accelerates formation of calcium sulfide dihydrate from the calcium sulfate hemihydrate. 6. The method of claim 5, wherein the accelerant is selected from the group consisting of calcium sulfate dihydrate, potassium sulfate, sodium sulfate, and mixtures thereof. 7. The method of claim 5, wherein the accelerant is calcium sulfide dihydrate coated with sucrose. 8. The method of claim 1, wherein the plasticizing material is selected from the group consisting of cellulose derivatives, glycerol, vinyl alcohols, stearic acid, hyaluronic acid, and mixtures thereof. 9. The method of claim 1, wherein the plasticizing material is selected from the group consisting of sodium carboxymethylcellulose, methylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose, ethylcellulose, hydroxyethylcellulose, cellulose acetate butyrate, and mixtures thereof. 10. The method of claim 1, wherein the aqueous mixing solution comprises sterile water, or sterile water comprising inorganic salts, cationic surface active agents, or combinations thereof. 11. The method of claim 1, further comprising mixing an additive into the blend or the mixture of the blend and the demineralized bone material, the additive being selected from the group consisting of bone marrow aspirate, platelet concentrate, blood, medicaments, pesticides, sodium bicarbonate, growth factors, bone morphogenic proteins, bone autograft, calcium phosphates, calcium carbonate, and mixtures thereof. 12. The method of claim 1, wherein the bone graft substitute composition has the consistency of a paste or putty, and can be applied to the site of a bone defect digitally or by injection. 13. method of claim 1 , wherein the demineralized bone material is in freeze-dried form and has a particle size of about 125 to about 850 microns. 14. The method of claim 1, wherein the bone graft substitute composition comprises: 100 parts of calcium sulfate hemihydrate; about 0.5 to about 5 parts of the plasticizing material; and about 10 to about 30 parts of demineralized bone. 15. The method of claim 5, wherein the bone graft substitute composition comprises: 100 parts of calcium sulfate hemihydrate; about 0.5 to about 5 parts of accelerant that accelerates formation of calcium sulfate dihydrate from the calcium sulfate hemihydrate; about 0.5 to about 5 parts of plasticizing material; and about 10 to about 30 parts of demineralized bone. 16. A kit for forming a bone graft substitute composition, comprising: a) a dry powder mixture of calcium sulfate hemihydrate and a plasticizing material; b) aqueous mixing solution; c) a demineralized bone material in particulate form; wherein a), b) and c) are separately packaged; and d) a set of instructions directing a kit user to perform the method of claim 1. 17. A method of making a bone graft substitute composition, comprising: a) mixing surgical grade calcium sulfate hemihydrate, a cellulose derivative, calcium sulfate dihydrate coated with sucrose, and an aqueous mixing solution for a time sufficient to form a blend; b) waiting a predetermined period of time after forming the blend, wherein said predetermined period of time is at least about thirty seconds; and then c) mixing the blend and a freeze-dried demineralized bone material to produce the bone graft substitute composition, wherein the bone graft substitute composition has the consistency of a paste or putty, and can be applied to the site of a bone defect digitally or by injection. 18. The method of claim 17, wherein the steps a) and b) have a combined time of at least about one minute. 19. A kit for forming a bone graft substitute composition, comprising, separately packaged: a) a dry powder mixture of calcium sulfate hemihydrite and a plasticizing material; b) an aqueous mixing solution; and c) a demineralized bone material in particulate form unblended with the dry powder mixture or the aqueous mixing solution. 20. The kit of claim 18, wherein the dry powder mixture further comprises an accelerant that accelerates formation of calcium sulfate dihydrate from the calcium sulfate hemihydrate. 21. The kit of claim 19, wherein the accelerant is calcium sulfide dihydrate coated with sucrose. 22. The kit of claim 18, wherein the plasticizing material is selected from the group consisting of cellulose derivatives, glycerol, vinyl alcohols, stearic acid, hyaluronic acid, and mixtures thereof. 23. The kit of claim 18, wherein the plasticizing material is selected from the group consisting of sodium carboxymethylcellulose, methylcellulase, hydroxypropylmethylcellulose, hydroxypropylcellulose, ethylcellulose, hydroxyethylccllulose, cellulose acetate butyrate, and mixtures thereof. 24. The kit of claim 18, wherein the demineralized bone material is in freeze-dried form and has a particle size of about 125 to about 850 microns.

Details for Patent 7,658,768

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2022-06-24